Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Idifarma Appoints Head of Site | Contract Pharma

What are you searching for?

Sign in

Idifarma Appoints Head of Site

Alfredo Gómez brings 20 years’ experience.

By: Contract Pharma

Contract Pharma Staff

Idifarma, a Spanish contract development and manufacturing organization (CDMO) specializing in niche and highly potent products, has appointed Alfredo Gómez as its head of site.
 
In his new role, Gómez will be responsible for ensuring the company continues to deliver tailored development, manufacturing, and regulatory solutions to pharma companies to speed up their path to market.
 
With over 20 years’ experience in strategic operations within the pharmaceutical industry, Gómez has joined the company from his most recent position at Praxis Pharmaceutical, where he was site director for almost a decade.
 
Idifarma believes his experience and expertise will support the planned expansion of the business across European and U.S. markets and in product areas with growing demand like oncology.
 
Commenting on his new role, Gómez said, “Idifarma is well respected in the industry with an impressive track record of operating with niche, innovative and highly potent oral drugs, and using flexibility and specialization to meet customer demands. I’m looking forward to contributing to its continued success and future growth.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters